Rezolute's Keith Vendola, Ph 2b Initiated, RZ358, Congenital Hyperinsulinism Transcript
Our next presenting company will be Rezolute, and presenting will be Keith Vendola, CFO. Keith?
Thank you for having me here today. I'm Keith Vendola, the CFO of Rezolute. It's a pleasure to be here. How about we start off with a little story? Imagine you have a child and imagine that for the past several years, you and he have been in and out of hospitals. Together, you've been navigating with a sports team of providers, endocrinologist, pediatricians, surgeons, and social workers, just to name a few.
The doctors have done workups and run blood tests. They've told you that certain genetic mutations within your child's pancreas are causing problems. His beta cells are putting out too much insulin and causing his blood sugar to drop. They've told you to watch this all the time.
Sugar is the main source of energy for his growing brain. If it gets too low, he could have brain damage for life or worse. You hope there's something out there that might help. They say
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |